Effects of Individual and Concurrent Stimulation of Striatal D₁ and D₂ Dopamine Receptors on Electrophysiological and Behavioral Output from Rat Basal Ganglia

Abstract

Bilateral infusions of d-amphetamine into the rat ventral-lateral striatum (VLS) were previously shown to cause a robust behavioral activation that was correlated temporally with a net increase in firing of substantia nigra pars reticulata (SNpr) neurons, a response opposite predictions of the basal ganglia model. The current studies assessed the individual and cooperative contributions of striatal D 1 and D 2 dopamine receptors to these responses. Bilateral infusions into VLS of the D 1 /D 2 agonist apomorphine (10 g/l/side) caused intense oral movements and sniffing, and an overall increase in SNpr cell firing to 133% of basal rates, similar to effects of d-amphetamine. However, when striatal D 2 receptors were stimulated selectively by infusions of quinpirole (30 g/l/side) ϩ the D 1 antagonist R-(ϩ) -7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SCH 23390; 10 g/l/ side), no behavioral response and only modest and variable changes in SNpr cell firing were observed. Selective stimulation of striatal D 1 receptors by (Ϯ) 6-chloro-APB hydrobromide (SKF 82958; 10 g/l/side) ϩ the D 2 antagonist cis-N-(1-benzyl-2-methyl-pyrrolidin-3-yl)-5-chloro-2-methoxy-4-methyl-aminobenzamide (YM 09151-2; 2 g/l/side) caused a weak but sustained increase in oral movements and modestly increased SNpr cell firing, but neither response was of the magnitude observed with apomorphine. When the two agonists were infused concurrently, however, robust oral movements and sniffing again occurred over the same time period that a majority of SNpr cells exhibited marked, sometimes extreme and fluctuating, changes in firing (net increase, 117% of basal rates). These data confirm that concurrent striatal D 1 /D 2 receptor stimulation elicits a strong motor activation that is correlated temporally with a net excitation rather than inhibition of SNpr firing, and reveal that D 1 and D 2 receptors interact synergistically within the striatum to stimulate both forms of output.The basal ganglia functional model predicts that dopamine, by stimulating the striatonigral pathway via D 1 receptors and inhibiting the striatopallidal pathway via D 2 receptors, should inhibit output from the substantia nigra pars reticulata and internal pallidal segment (SNpr/GPi). Inhibition of output from the SNr/GPi should in turn disinhibit the thalamus to facilitate movement (for review, see Alexander and Crutcher, 1990). Many of the predictions of the model have been supported by electrophysiological studies in humans with Parkinson's disease and animal models of this disorder (Filion and Tremblay, 1991;Bergman et al., 1994;Papa et al., 1999;Levy et al., 2001). However, the question of whether these predictions are valid and supported in normal animals without dopaminergic lesions has been less rigorously addressed.A definitive test of this hypothesis has been made difficult by the complexity of the circuitry, in particular by the fact that D 1 and D 2 receptors are expressed not only within the striatum but also in other nuclei of th...

Morphine-Induced c-fos mRNA Expression in Striatofugal Circuits: Modulation by Dose, Environmental Context, and Drug History

“…Consistent with our results, morphine infused directly into the substantia nigra leads to a negative correlation between rotational behavior and cFos expression in the dorsomedial CPu (Bontempi and Sharp, 1997). These findings are also in agreement with recent reports that intrastriatal infusions of dopamine agonists, which increase locomotor activity, also increase neuronal firing in basal ganglia output nuclei (Waszczak et al, 2001(Waszczak et al, , 2002, and that intravenous infusions of dopamine agonists, at doses that are sufficient to induce rotational behavior and increase c-Fos in both striatofugal pathways, did not decrease the firing rate of basal ganglia output nuclei (Ruskin et al, 1999).…”

A Physiologically Plausible Model of Action Selection and Oscillatory Activity in the Basal Ganglia

“…This is consistent with the behavioral stereotypies expressed by rats after systemic or intrastriatal injections of the dopamine stimulant amphetamine (Wang and Rebec, 1993;Waszczak et al, 2001;Gulley et al, 2004) or intrastriatal injections of nonselective dopamine agonists (Waszczak et al, 2002). Thus, the effects of dopamine depletion and dopamine excess in the model are both consistent with the known behavioral impact of these manipulations.…”

Lack of Self-Administration of Cocaine in Dopamine D1Receptor Knock-Out Mice

“…For example, both pharmacological blockade and gene knock-out of the dopamine D 1 receptor attenuated the physiological effects of dopamine and D 1 -and D 2 -selective agonists Clark and White, 1987;Walters et al, 1987;White et al, 1988;Wachtel et al, 1989;Johansen et al, 1991;Xu et al, 1994a,b;Cooper et al, 1998;Waszczak et al, 2002). Conversely, D 1 stimulation enabled the full expression of behavioral effects and molecular and cellular adaptations induced by dopamine indirect and direct D 1 and D 2 agonists White et al, 1988;Xu et al, 1994a,b;Gerfen et al, 1995;Keefe and Gerfen, 1995;Xu et al, 2000;RalphWilliams et al, 2002;Waszczak et al, 2002;Fetsko et al, 2003;Zhang et al, 2004;Ralph and Caine, 2005;Zhang et al, 2005;Zhang et al, 2006).…”